Immunomedics
Biotechnology ResearchNew Jersey, United States201-500 Employees
Immunomedics is a leader in next-generation antibody-drug conjugate (ADC) technology, committed to help transform the lives of people with hard-to-treat cancers.
Insights
ADC Technology Leader Immunomedics is a leading provider of next-generation antibody-drug conjugate (ADC) technology, offering innovative solutions to address hard-to-treat cancers. This expertise presents sales opportunities for collaborations with pharmaceutical companies seeking to enhance their oncology product portfolios.
Strategic Partnerships Immunomedics has engaged in strategic partnerships with major players like Roche Canada and Gilead Sciences, resulting in significant acquisitions and collaborative clinical trials. Leveraging these partnerships, sales professionals can explore cross-selling opportunities and expand market reach by tapping into established networks.
Revenue and Funding With reported annual revenue in the range of $50M - $100M and significant funding of $250M, Immunomedics displays financial stability and growth potential. Sales teams can target the company as a high-value client for products or services that complement its biotechnology research operations.
Industry Acquisitions Immunomedics was acquired by Trodelvy and subsequently by Gilead Sciences, indicating industry recognition and investment in its assets. Sales representatives can capitalize on this by positioning their offerings as integral to supporting Immunomedics' continued success and expansion within the biotechnology sector.
Talent Acquisition Key personnel movements, such as the departure of the former general counsel and subsequent hiring at Intercept, create sales opportunities for legal and consulting services providers targeting executives transitioning between prominent biotech firms. Building relationships with Immunomedics alumni can open doors to new business prospects.
Similar companies to Immunomedics
Immunomedics Tech Stack
Immunomedics uses 8 technology products and services including Google Analytics, WordPress, MySQL, and more. Explore Immunomedics's tech stack below.
- Google AnalyticsAnalytics
- WordPressContent Management System
- MySQLDatabase
- Amazon Web ServicesPlatform As A Service
- PHPProgramming Languages
- Yoast SEOSearch Engines
- BootstrapUI Frameworks
- OpenSSLWeb Server Extensions
Media & News
Immunomedics's Email Address Formats
Immunomedics uses at least 1 format(s):
| Immunomedics Email Formats | Percentage |
| FLast@immunomedics.com | 91% |
| FirstLast@immunomedics.com | 4% |
| First.Last@immunomedics.com | 3% |
| Last@immunomedics.com | 2% |
Frequently Asked Questions
Where is Immunomedics's headquarters located?
Immunomedics's main headquarters is located at 300 The American Rd Morris Plains, New Jersey 07950 US. The company has employees across 4 continents, including North AmericaEuropeAsia. What is Immunomedics's phone number?
You can contact Immunomedics's main corporate office by phone at +1-973-605-****
What is Immunomedics's stock symbol?
Immunomedics is a publicly traded company; the company's stock symbol is IMMU. What is Immunomedics's official website and social media links?
Immunomedics's official website is immunomedics.com and has social profiles on LinkedIn.How much revenue does Immunomedics generate?
As of November 2024, Immunomedics's annual revenue reached $75M. What is Immunomedics's SIC code NAICS code?
Immunomedics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Immunomedics have currently?
As of November 2024, Immunomedics has approximately 201 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer And Founder: M. D.Chief Commercial Officer: B. D.Chief Quality Officer: B. B.. Explore Immunomedics's employee directory with LeadIQ.What industry does Immunomedics belong to?
Immunomedics operates in the Biotechnology Research industry. What technology does Immunomedics use?
Immunomedics's tech stack includes Google AnalyticsWordPressMySQLAmazon Web ServicesPHPYoast SEOBootstrapOpenSSL. What is Immunomedics's email format?
Immunomedics's email format typically follows the pattern of . Find more Immunomedics email formats with LeadIQ. How much funding has Immunomedics raised to date?
As of November 2024, Immunomedics has raised $250M in funding. The last funding round occurred on Dec 04, 2019 for $250M.When was Immunomedics founded?
Immunomedics was founded in 1982.
Company Overview
- Headquarters
- 300 The American Rd Morris Plains, New Jersey 07950 US
- Phone number
- +1-973-605-****
- Website
- immunomedics.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- IMMU
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 1982
- Employees
- 201-500
Media & News
Funding & Financials
- $250M
Immunomedics has raised a total of $250M of funding over 6 rounds. Their latest funding round was raised on Dec 04, 2019 in the amount of $250M.
- $50M$100M
Immunomedics's revenue is in the range of $50M$100M
Funding & Financials
- $250M
Immunomedics has raised a total of $250M of funding over 6 rounds. Their latest funding round was raised on Dec 04, 2019 in the amount of $250M.
- $50M$100M
Immunomedics's revenue is in the range of $50M$100M
Company Leadership
M. D.Chief Executive Officer And Founder
B. D.Chief Commercial Officer- B. B.Chief Quality Officer
- A. K.Vice President Quality
P. I.Head Of Research And Development And Chief Medical Officer
Employee Directory
- M. D.Chief Executive Officer And Founder
- P. I.Head Of Research And Development And Chief Medical Officer
- R. P.President
- E. R.Associate Vice President, Process Development And Manufacturing
- A. S.Global Vice President Of Engineering
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
